Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Revance Therapeutics, Inc. NASDAQ-GM
Wall Street employs a veritable army of stock analysts who spend all of their time analyzing companies, issuing earnings guidance and providing "Buy" and "Sell" recommendations on those companies. Learn more about how you can use Analyst Research in your own trading.
Detailed Analyst Recommendation
Each Recommendation received from contributors is mapped to one of the Zacks standard ratings. A consensus recommendation is determined by an average of the numeric values, rounding that mean value to the nearest integer. This area currently displays US research coverage only. In many cases, non-US related research coverage can be accessed from the homepage of the respective company.
12-Month Price Target Range
The 12-month Consensus Price Target is the average of individual price target estimates submitted by covering sell-side analysts.
12/2018 0 of 3 estimates changed
Estimate momentum measures changes in analyst sentiment over time & may be an indicator of future price movements.
Earnings Growth (2018)
Earnings Growth is the measure of year on year earnings per share (EPS) growth from the prior fiscal year, expressed as a percentage.
Price / Earnings (2018)
Price/Earnings ratio is a widely used stock evaluation measure. View P/E data for the next four years for this security.
View earnings surprise data table for more information.
Consensus Earnings Forecast
PEG ratio is the Price Earnings ratio divided by the growth rate. In this case we use the forecasted earnings over the next 12 months & the long term forecasted growth rate (based on the consensus of professional analysts).
You have selected to change your default setting for the Quote Search. This will now be your default target page;
unless you change your configuration again, or you delete your
cookies. Are you sure you want to change your settings?
The actual reported earnings per share for 12/2017 for RVNC was -4.01 For the fiscal year 12/2018, the consensus mean EPS is -3.81, derived from a total of 3 estimate.
Customize your NASDAQ.com experience
Background Color Selector
Select the background color of your choice:
Select a default target page for your quote search:
If you have any questions or encounter any issues in changing your default settings, please email email@example.com.
Please confirm your selection: